Stratagene Acquires Rights to microRNA Sequences
Co-Exclusive License Provides Access to More Than 150 microRNA Sequences for the Development, Manufacture and Sale of Molecular Diagnostic Kits
MicroRNAs are naturally occurring, small RNAs that act to regulate messenger RNA, or mRNA, expression in humans. Currently there are in excess of 300 microRNA's identified and research in this field is likely to push this number much higher. MicroRNAs are believed to regulate many genes, and thus are thought to be good indicators for biomarkers that are associated with many diseases. Of particular interest to Stratagene is the association of microRNAs with cancer.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.